This was present in some cohorts in METASTROKE and might have attenuated any association with MTHFR C677T in METASTROKE.15 In the present study, folic acid fortification was not used in any of the included stroke cohorts, but was used in some of the included WMH volume cohorts. The gene discussed is MTHFR; the disease is stroke disorder.